Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Here, we present the case of a large family, in which a single TNNI3 mutation caused variable phenotypic expression, ranging from restrictive cardiomyopathy (RCMP) to hypertrophic cardiomyopathy (HCMP) to near-normal phenotype.
|
28382084 |
2017 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A Double Heterozygous Mutation of TNNI3 Causes Hypertrophic Cardiomyopathy in a Han Chinese Family.
|
26506446 |
2016 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We investigated the effect of the hypertrophic cardiomyopathy-linked R21C (arginine to cysteine) mutation in human cardiac troponin I (cTnI) on the contractile properties and myofilament protein phosphorylation in papillary muscle preparations from left (LV) and right (RV) ventricles of homozygous R21C(+/+) knock-in mice.
|
25961037 |
2015 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy-Associated Mutation in Human Cardiac Troponin I (K206I).
|
26553696 |
2015 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
PosttranslationalModification
|
disease |
BEFREE |
Dilated and hypertrophic cardiomyopathy mutations in troponin can blunt effects of protein kinase A (PKA) phosphorylation of cardiac troponin I (cTnI), decreasing myofilament Ca2+-sensitivity; however this effect has never been tested for restrictive cardiomyopathy (RCM) mutants.
|
25450489 |
2015 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy.
|
22086914 |
2012 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians.
|
22876777 |
2012 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
One contractile protein gene well known as a hypertrophic cardiomyopathy disease gene, but with no reported mutation in autosomal dominant DCM, is TNNI3 which encodes cardiac troponin I.
|
19590045 |
2009 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice.
|
18430738 |
2008 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The TNNI3 alteration, replacing proline with serine (Pro82Ser), has been previously implicated in elderly-onset hypertrophic cardiomyopathy, although its pathogenicity is not clear.
|
18175163 |
2008 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.
|
15698845 |
2005 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The inability of the five cTnI mutations investigated to fully inhibit ATPase activity/force development and the generally larger increases in Ca2+ sensitivity than observed for most hypertrophic cardiomyopathy mutations would likely lead to severe diastolic dysfunction and may be the major physiological factors responsible for causing the restrictive cardiomyopathy phenotype in some of the genetically affected individuals.
|
15961398 |
2005 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
|
15607392 |
2004 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion.
|
12109867 |
2002 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.
|
10806205 |
2000 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, we describe a non-Japanese family in which hypertrophic cardiomyopathy is due to a genetic defect in the cardiac troponin I gene.
|
10731450 |
2000 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The results of the present study indicate that defects in the cardiac troponin I gene do not cause hypertrophic cardiomyopathy in patients from Eastern Finland.
|
10591029 |
1999 |
Hypertrophic obstructive cardiomyopathy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy.
|
9241277 |
1997 |